Cyclomics B.V.

Company Snapshot

Founded: 2017
Entity Type: Private
Region: The Netherlands
Headquarter: Utrecht, The Netherlands
Key Geographics: Europe
Corporate Address: Matrix ONE building Science Park 301 1098XH Amsterdam Netherlands www.cyclomics.com

Company Overview

Cyclomics, founded as a spinout from UMC Utrecht, is developing and commercializing liquid biopsy diagnostics for cancer care using proprietary ctDNA detection technology involving nanopore sequencing.

Cyclomic’s technology is called CyclomicsSeq; the technology is very sensitive, with even a single ctDNA molecule present in blood being detected and sequenced at close to 100% accuracy. The technology uses a combination of proprietary DNA adapters (backbones) and enzymes to capture ctDNA molecules and circularize them. This circular DNA is then amplified (via rolling circle amplification), creating long DNA concatemers, which are sequenced using long-read (nanopore) technology.

The company’s initial focus is on head and neck cancers (HNC), for which monitoring of treatment response and recurrence diseases is key to improving survival.

Cyclomics B.V. In Reports

Next-generation Sequencing: Emerging Clinical Applications and Global Markets

Discover BCC Research's report on Next-generation Sequencing Market is steadily being integrated into clinical laboratory analysis, testing, and disease diagnostics in healthcare sectors globally.

Next-generation Sequencing: Emerging Clinical Applications and Global Markets

BCC Research Market Report says clinical next-generation sequencing (NGS) should grow from $5.9 billion in 2020 to $22.9 billion by 2025 with a (CAGR) of 31.4%.

Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets

BCC Market Research Report for global liquid biopsy research tools, liquid biopsy biomarkers, technologies, services and diagnostics markets.

Company's Business Segments

  • Sequencing Solutions : The company offers ultra-sensitive diagnostic tests for cancer detection and recurrence monitoring using a liquid biopsy method called CyclomicsSeq.

Applications/End User Industries

  • Oncology
  • Contract Research Organizations
  • Life Sciences Research
  • Life Sciences
  • Hospitals
  • Diagnostics
  • Healthcare
  • AI in Diagnostics
  • AI in Cancer Diagnostics
  • Diagnosis Center
AI Sentiment